Breast. 2003 Dec;12(6):397-404.

Evaluation of bone marrow in breast cancer patients: prediction of clinical outcome and response to therapy.

Braun S, Vogl FD, Janni W, Marth C, Schlimok G, Pantel K.

Source

Department of Ob/Gyn, University Hospital, Innsbruck, Austria. stephan.braun@uklibk.ac.at

Abstract

Blood-borne distant metastasis is the leading cause of cancer-related death in breast cancer. The onset of this fundamental process can now be assessed in cancer patients by using ultrasensitive immunocytochemical and molecular assays able to detect even single metastatic cells. To date, clinical studies with large study populations, validated immunoassays, and adequate follow-up time provide evidence for the independent prognostic value of the presence of disseminated tumor cells in the bone marrow. At present, bone marrow evaluation may therefore be considered a diagnostic tool for improved risk assessment with regard to distant relapse and death, especially among potentially curable breast cancer patients. Except for promising pilot studies, no data are available to support the immediate use of bone marrow evaluation for treatment monitoring in order to enable the prediction of response to adjuvant therapy.

PMID:: 14659112; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

Keratins

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Breast Cancer - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Detection and clinical implications of early systemic tumor cell dissemination in breast cancer. [Clin Cancer Res. 2003]
Detection and clinical implications of early systemic tumor cell dissemination in breast cancer.
Pantel K, Müller V, Auer M, Nusser N, Harbeck N, Braun S. Clin Cancer Res. 2003 Dec 15; 9(17):6326-34.
Review Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization. [Pathobiology. 2008]
Review Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
Riethdorf S, Pantel K. Pathobiology. 2008; 75(2):140-8. Epub 2008 Jun 10.
Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: results at 4 years. [Int J Cancer. 2005]
Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: results at 4 years.
Slade MJ, Singh A, Smith BM, Tripuraneni G, Hall E, Peckitt C, Fox S, Graham H, Lüchtenborg M, Sinnett HD, et al. Int J Cancer. 2005 Mar 10; 114(1):94-100.
Review Overview of resistance to systemic therapy in patients with breast cancer. [Adv Exp Med Biol. 2007]
Review Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN. Adv Exp Med Biol. 2007; 608:1-22.
Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse. [Clin Cancer Res. 2008]
Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse.
Bidard FC, Vincent-Salomon A, Gomme S, Nos C, de Rycke Y, Thiery JP, Sigal-Zafrani B, Mignot L, Sastre-Garau X, Pierga JY, et al. Clin Cancer Res. 2008 Jun 1; 14(11):3306-11.

See reviews... See all...

Cited by 2 PubMed Central articles

Review Genetic and epigenetic alterations in breast cancer: what are the perspectives for clinical practice? [Int J Biochem Cell Biol. 2008]
Review Genetic and epigenetic alterations in breast cancer: what are the perspectives for clinical practice?
Fucito A, Lucchetti C, Giordano A, Romano G. Int J Biochem Cell Biol. 2008; 40(4):565-75. Epub 2007 Oct 23.
Real-time RT-PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer. [Br J Cancer. 2006]
Real-time RT-PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer.
Benoy IH, Elst H, Philips M, Wuyts H, Van Dam P, Scharpé S, Van Marck E, Vermeulen PB, Dirix LY. Br J Cancer. 2006 Mar 13; 94(5):672-80.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Evaluation of bone marrow in breast cancer patients: prediction of clinical outc...
Evaluation of bone marrow in breast cancer patients: prediction of clinical outcome and response to therapy.
Breast. 2003 Dec ;12(6):397-404.

PubMed
Bringing order to the glutamate chaos in schizophrenia.
Bringing order to the glutamate chaos in schizophrenia.
Neuron. 2003 Dec 4 ;40(5):881-4.

PubMed
Localizing the proteome.
Localizing the proteome.
Genome Biol. 2003 ;4(12):240. Epub 2003 Nov 18 .

PubMed
Multi-species sequence comparison: the next frontier in genome annotation.
Multi-species sequence comparison: the next frontier in genome annotation.
Genome Biol. 2003 ;4(12):122. Epub 2003 Nov 27 .

PubMed
Divalproex sodium for the treatment of conduct disorder: a randomized controlled...
Divalproex sodium for the treatment of conduct disorder: a randomized controlled clinical trial.
J Clin Psychiatry. 2003 Oct ;64(10):1183-91.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: